![](/img/cover-not-exists.png)
Carden MA, Gaddh M, Hoskote A, et al. Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020;4(3):477-481.
Volume:
4
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2020001818
Date:
March, 2020
File:
PDF, 529 KB
2020